Track topics on Twitter Track topics that are important to you
Gene therapy developer Voyager Therapeutics (NASDAQ: VYGR) has lost its chief operating officer. Matthew Ottmer, who held the role since September 2017, resigned effective Feb. 12, according to a Friday securities filing. No reason was given. Though Ottmer has stepped down from his executive role, he will remain an at-will employee of Cambridge, MA-based Voyager […]
Original Article: Voyager Therapeutics Chief Operating Officer Matthew Ottmer ResignsNEXT ARTICLE
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...